- Home
- SGN vs GCTK Comparison
SGN vs GCTK Comparison
Compare SGN & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGN
- GCTK
- Stock Information
- Founded
- SGN 2019
- GCTK 2001
- Country
- SGN United States
- GCTK United States
- Employees
- SGN N/A
- GCTK N/A
- Industry
- SGN
- GCTK Medical/Dental Instruments
- Sector
- SGN
- GCTK Health Care
- Exchange
- SGN Nasdaq
- GCTK Nasdaq
- Market Cap
- SGN 3.8M
- GCTK 4.1M
- IPO Year
- SGN 2023
- GCTK N/A
- Fundamental
- Price
- SGN $1.08
- GCTK $6.59
- Analyst Decision
- SGN
- GCTK
- Analyst Count
- SGN 0
- GCTK 0
- Target Price
- SGN N/A
- GCTK N/A
- AVG Volume (30 Days)
- SGN 1.3M
- GCTK 1.6M
- Earning Date
- SGN 08-18-2025
- GCTK 08-12-2025
- Dividend Yield
- SGN N/A
- GCTK N/A
- EPS Growth
- SGN N/A
- GCTK N/A
- EPS
- SGN N/A
- GCTK N/A
- Revenue
- SGN $529,282.00
- GCTK N/A
- Revenue This Year
- SGN N/A
- GCTK N/A
- Revenue Next Year
- SGN N/A
- GCTK N/A
- P/E Ratio
- SGN N/A
- GCTK N/A
- Revenue Growth
- SGN 8.42
- GCTK N/A
- 52 Week Low
- SGN $0.44
- GCTK $5.16
- 52 Week High
- SGN $36.70
- GCTK $3,756.00
- Technical
- Relative Strength Index (RSI)
- SGN 52.82
- GCTK 35.94
- Support Level
- SGN $0.92
- GCTK $5.94
- Resistance Level
- SGN $1.35
- GCTK $15.90
- Average True Range (ATR)
- SGN 0.17
- GCTK 1.57
- MACD
- SGN -0.02
- GCTK -0.01
- Stochastic Oscillator
- SGN 46.94
- GCTK 0.56
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.